SEC Filings | Landos Biopharma

Filing date	Form	Description	View
08/23/19	D	Notice of Exempt Offering of Securities	0001785345-19-000001.pdf 95.6 KB 0001785345-19-000001.rtf View HTML
07/24/20	DRS	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	0000950123-20-007158.pdf 4.4 MB 0000950123-20-007158.rtf 0000950123-20-007158.xls View HTML
08/20/20	UPLOAD	UPLOAD	0000000000-20-007758.pdf 0000000000-20-007758.rtf View HTML
09/01/20	DRS/A	Amendment to a previously filed DRS	0000950123-20-009456.pdf 5.4 MB 0000950123-20-009456.rtf 0000950123-20-009456.xls View HTML
09/15/20	UPLOAD	UPLOAD	0000000000-20-008692.pdf 0000000000-20-008692.rtf View HTML
11/30/20	DRS/A	Amendment to a previously filed DRS	0000950123-20-012413.pdf 6.6 MB 0000950123-20-012413.rtf 0000950123-20-012413.xls View HTML
12/15/20	UPLOAD	UPLOAD	0000000000-20-011972.pdf 0000000000-20-011972.rtf View HTML
01/13/21	S-1	Registration statement for face-amount certificate companies	0001193125-21-008210.pdf 8 MB 0001193125-21-008210.rtf 0001193125-21-008210.xls View HTML
01/13/21	CORRESP	CORRESP	0001193125-21-008217.pdf 128.8 KB 0001193125-21-008217.rtf View HTML
01/26/21	UPLOAD	UPLOAD	0000000000-21-000934.pdf 64 KB 0000000000-21-000934.rtf View HTML

Data provided by Kaleidoscope.